18th April 2020
Nori Health available for free to support IBD sufferers during the outbreak
Nori Health, a chatbot that helps manage chronic diseases seeks partnerships with hospitals and pharmaceutical companies to offer free access to its service.
Nori Health is a digital lifestyle coach for people living with Inflammatory bowel disease (IBD, Crohn’s and colitis). Nori Health is designed to help patients improve health behaviours and enhance mental strength, alongside medical treatment.
Since COVID-19 recovery can be dependent on the strength of the immune system, risks are often higher when it comes to people living with a chronic disease, such as Crohn’s or colitis. As such, sufferers may be isolated for many weeks to come. Understanding the challenges facing this community, Nori Health is extending their support and offering free access to the digital coach for patients by partnering with hospitals and pharmaceutical companies.
The programme that is currently implemented within a number of hospitals and health systems across Europe provides a platform for safe and anonymous chat conversations across 100+ evidence-based topics.
By providing evidence-based guidance and support to patients when they need it, Nori can help to relieve clinical workload and reduce the volume of support required by healthcare professionals.
Hospitals who partner with Nori Health will receive a unique access code for monitoring patient engagement and results. Hospitals can monitor the incoming calls/questions from patients to study the impact of the programme. Nori Health is a standalone platform with no integration needed, so patients can get access within hours.
Pharmaceutical companies are also welcome to contribute as sponsors, as Nori Health is currently fast tracking the discovery phase for Rheumatoid Arthritis to launch a programme tailored to the unique needs of that patient demographic.
Nori Health is currently available for free until June 1 2020, and access may be extended at that point.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody